Ekonomičnost alternativ transfuziji krvi
Onkologija
Should intravenous iron be the standard of care in oncology? (odpre novo okno)
Vir: J Clin Oncol 2008;26(10):1579-81.
Indeksirano: PubMed 18375888
DOI: 10.1200/JCO.2007.15.4609
https://www.ncbi.nlm.nih.gov/pubmed/18375888 (odpre novo okno)
The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model. (odpre novo okno)
Vir: Acta Oncol 2008;47(6):1009-17.
Indeksirano: PubMed 18770060
DOI: 10.1080/02841860701744498
https://www.ncbi.nlm.nih.gov/pubmed/18770060 (odpre novo okno)
Cost of outpatient blood transfusion in cancer patients. (odpre novo okno)
Vir: J Clin Oncol 2000;18(14):2755-61.
Indeksirano: PubMed 10894876
DOI: 10.1200/JCO.2000.18.14.2755
https://www.ncbi.nlm.nih.gov/pubmed/10894876 (odpre novo okno)
Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (odpre novo okno)
Vir: Transfusion 2015;55(12):2807-15.
Indeksirano: PubMed 26264557
DOI: 10.1111/trf.13260
https://www.ncbi.nlm.nih.gov/pubmed/26264557 (odpre novo okno)